Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;598(14):3015-3027.
doi: 10.1113/JP276746. Epub 2019 Jul 26.

Mechanisms underlying the cross-talk between heart and cancer

Mara Brancaccio  1 , Flora Pirozzi  2 , Emilio Hirsch  1 , Alessandra Ghigo  1
Affiliations
Free article
Review

Mechanisms underlying the cross-talk between heart and cancer

Mara Brancaccio et al. J Physiol. 2020 Jul.
Free article

Abstract

Cardiovascular diseases and cancer remain the leading cause of death worldwide. Despite the fact that these two conditions have long been considered as distinct clinical entities, recent epidemiological and experimental studies suggest that they should be contemplated and treated as co-morbidities. Heart failure represents nowadays a well-established complication of cancer, primarily as a consequence of the aggressive use of cardiotoxic anti-cancer treatments. On the other hand, the provocative idea that heart failure can prime carcinogenesis has started to emerge, though the molecular basis is still to be fully elucidated. This review summarizes the current knowledge on the mechanisms underlying the bidirectional communication between the failing heart and the cancer. We will discuss and/or speculate on the role of molecular mediators released by either the tumour or the heart that can potentially link heart failure and cancer.

Keywords: cancer; co-morbidities; cross-talk; heart failure; inflammation.

PubMed Disclaimer

References

    1. Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, Farmakis D, Lopez-Fernandez T, Lainscak M, Pudil R, Ruschitska F, Seferovic P, Filippatos G, Coats A, Suter T, Von Haehling S, Ciardiello F, de Boer RA, Lyon AR & Tocchetti CG (2018). Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 20, 879-887.
    1. Assuncao B, Handschumacher MD, Brunner AM, Yucel E, Bartko PE, Cheng KH, Campos O, Fathi AT, Tan TC & Scherrer-Crosbie M (2017). Acute leukemia is associated with cardiac alterations before chemotherapy. J Am Soc Echocardiogr 30, 1111-1118.
    1. Badiani S, van Zalen J, Treibel TA, Bhattacharyya S, Moon JC & Lloyd G (2016). Aortic stenosis, a left ventricular disease: insights from advanced imaging. Curr Cardiol Rep 18, 80.
    1. Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ & Carson JA (2008). Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol 294, R393-R401.
    1. Banke A, Schou M, Videbaek L, Moller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Kober L, Hildebrandt PR & Gislason GH (2016). Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail 18, 260-266.

Publication types

LinkOut - more resources